Narrative Intervention for Long COVID-19 (NICO)
NICO
1 other identifier
interventional
12
1 country
1
Brief Summary
This T1 proof of concept trial is designed to test the Narrative Intervention for Long COVID-19 intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2022
CompletedFirst Submitted
Initial submission to the registry
October 18, 2023
CompletedFirst Posted
Study publicly available on registry
October 19, 2023
CompletedDecember 10, 2024
December 1, 2024
2 months
October 18, 2023
December 5, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Personal Health Questionnarrie- 8 item (PHQ8)
Measurement of depression widely used in clinical and research settings
Baseline and 3 months
Secondary Outcomes (1)
Generalized Anxiety Disorder- 7 item (GAD7)
Baseline and 3 months
Study Arms (1)
NICO
EXPERIMENTALThe NICO intervention includes components of narrative-informed interventions, brief solution-focused therapy, and medical social work case management to examine adjustment to illness for people living with Long COVID.
Interventions
The NICO intervention was delivered by a licensed psychotherapist asynchronously over a 3 month time period.
Eligibility Criteria
You may qualify if:
- Diagnosed with Long COVID
- Have access to email weekly
- Between the ages of 18-89 years old
You may not qualify if:
- Conflicting research study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Colorado Anschutz Medical Campus
Aurora, Colorado, 80045, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rachel Johnson, PhD, LCSW
University of Colorado, Denver
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 18, 2023
First Posted
October 19, 2023
Study Start
October 1, 2022
Primary Completion
December 1, 2022
Study Completion
December 1, 2022
Last Updated
December 10, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share